| Patent No. | Patent Title: |
| 5462862 | Method and compositions for enhancing production of secondary ... |
| 5459056 | Human T cell line chronically infected with HIV |
| 5453361 | Method for producing biologically active human brain derived ... |
| 5444155 | Molecules with antibody combining sites that induce asymmetry |
| 5438121 | Brain derived neurotrophic factor |
| 5433945 | Immunoprotective genetically-detoxified mutants of pertussis toxi... |
| 5427940 | Engineered cells producing insulin in response to glucose |
| 5424400 | Senescent cell derived inhibitors of DNA synthesis |
| 5418135 | Method of inhibiting binding of PDGF to a PDGF receptor by biosyn... |
| 5415874 | Natural killer cell lines and clones with antigen specificity |
| 5413918 | Gene and method for production of a 40-45-kDa IgA binding protein |
| 5385831 | Method for producing a mammalian G protein coupled glutamate rece... |
| 5384243 | Method for screening an agent for its ability to prevent cell ... |
| 5382658 | Stability-enhanced variants of parathyroid hormone |
| 5378819 | Systemin, an inducer of plant defense proteins, and methods of us... |
| 5364785 | Method of isolating lung cell line |
| 5359046 | Chimeric chains for receptor-associated signal transduction pathw... |
| 5358868 | Genetic detoxification of pertussis toxin |
| 5359036 | Growth hormone-like glycoproteins |
| 5359033 | Cleaved dimers of mullerian inhibiting substance-like polypeptide... |
| 5354674 | Method of gene transfer using retrotransposons |
| 5354677 | Intracellular phospholipase A2 enzyme |
| 5348872 | Method for isolating mutant cells |
| 5344764 | Protein inhibitors of phospholipase A2 purified from i... |
| 5342777 | Cell culture medium for human liver epithelial cell line |
| 5340726 | Protein for inhibiting collagen-stimulated platelet aggregation |
| 5336667 | Method for inhibiting the ahesion of platelet with alboaggregins:... |
| 5332583 | Vaccine containing genetically-detoxified pertussis holotoxin |
| 5328840 | Method for preparing targeted carrier erythrocytes |
| 5324654 | Method for reversibly increasing proliferation of a non-malignant... |
| 5324645 | Highly retrovirus-producing DNA construct and cell line |
| 5322776 | DNA sequences encoding phospholipase A2 enzyme and pro... |
| 5320947 | Immune reactivity to expressed activated oncogenes for diagnosis ... |
| 5316754 | In vitro assay of mesangial cell-derived receptors for advanced ... |
| 5317088 | C-terminal conglutinin fragments coupled to solid support |
| 5316919 | Method of producing 2 KD to 10 KD peptides having no L-methionine... |
| 5312734 | CDNA encoding a dopamine transporter |
| 5310648 | Composition of matter comprising an imprinted matrix exhibiting ... |
| 5304634 | Inhibitors for the formation of tumor necrosis factor |
| 5302706 | Senescent cell derived inhibitors of DNA synthesis |
Bizarre Patents 
PatentStorm News
